Sandra Koch

3.5k total citations
59 papers, 1.7k citations indexed

About

Sandra Koch is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Sandra Koch has authored 59 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hepatology, 24 papers in Epidemiology and 14 papers in Oncology. Recurrent topics in Sandra Koch's work include Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Liver Disease Diagnosis and Treatment (16 papers) and Liver Disease and Transplantation (9 papers). Sandra Koch is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Liver Disease Diagnosis and Treatment (16 papers) and Liver Disease and Transplantation (9 papers). Sandra Koch collaborates with scholars based in Germany, United States and France. Sandra Koch's co-authors include Arndt Weinmann, Peter R. Galle, Thomas F. Schulz, Christoph Düber, Gerd Otto, Marcus A. Wörns, Carsten Bokemeyer, Frank Mayer, Marcus Schuchmann and Friedemann Honecker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Clinical Oncology.

In The Last Decade

Sandra Koch

57 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Koch Germany 27 555 536 382 319 285 59 1.7k
Kazuyoshi Ohkawa Japan 29 1.0k 1.8× 798 1.5× 618 1.6× 710 2.2× 281 1.0× 158 2.4k
Masaaki Kondo Japan 24 733 1.3× 487 0.9× 328 0.9× 318 1.0× 434 1.5× 91 1.6k
Sabino Russi Italy 19 497 0.9× 288 0.5× 254 0.7× 135 0.4× 299 1.0× 45 1.3k
Abeer A. Bahnassy Egypt 24 490 0.9× 450 0.8× 516 1.4× 501 1.6× 287 1.0× 89 1.6k
Mee Soo Chang South Korea 26 251 0.5× 721 1.3× 515 1.3× 744 2.3× 460 1.6× 106 2.2k
Shilpa Chokshi United Kingdom 26 1.2k 2.1× 1.2k 2.2× 425 1.1× 248 0.8× 163 0.6× 72 2.1k
Hyun Young Woo South Korea 22 757 1.4× 515 1.0× 179 0.5× 329 1.0× 246 0.9× 71 1.3k
H. P. Dienes Germany 20 592 1.1× 481 0.9× 334 0.9× 188 0.6× 300 1.1× 50 1.3k
Abdel‐Rahman N. Zekri Egypt 29 792 1.4× 832 1.6× 1.0k 2.7× 679 2.1× 381 1.3× 159 2.7k
Liming Chen China 16 351 0.6× 208 0.4× 494 1.3× 181 0.6× 348 1.2× 54 1.3k

Countries citing papers authored by Sandra Koch

Since Specialization
Citations

This map shows the geographic impact of Sandra Koch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Koch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Koch more than expected).

Fields of papers citing papers by Sandra Koch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Koch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Koch. The network helps show where Sandra Koch may publish in the future.

Co-authorship network of co-authors of Sandra Koch

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Koch. A scholar is included among the top collaborators of Sandra Koch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Koch. Sandra Koch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sielaff, Malte, Sandra Koch, Khaoula El Hassouni, et al.. (2024). Su1345 TLR4 STIMULATING BIOACTIVITY OF WHEAT ATIS VARIES BASED ON THE LOCATION OF CULTIVATION. Gastroenterology. 166(5). S–738.
2.
Koch, Sandra, et al.. (2024). Impact of Physiological Fluctuations of Sex Hormones During the Menstrual Cycle on Glucose Metabolism and the Gut Microbiota. Experimental and Clinical Endocrinology & Diabetes. 132(5). 267–278. 7 indexed citations
3.
Geißlitz, Sabrina, Sandra Koch, Heiko Weichert, et al.. (2023). Breeding from 1891 to 2010 did not increase the content of amylase/trypsin-inhibitors in wheat (Triticum aestivum). npj Science of Food. 7(1). 43–43. 6 indexed citations
4.
Scheiner, Bernhard, Torsten Voigtländer, Sandra Koch, et al.. (2019). Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma. Liver International. 39(4). 714–726. 48 indexed citations
5.
Koch, Sandra, Elias Hage, Akshay Dhingra, et al.. (2019). Kaposi’s sarcoma-associated herpesvirus vIRF2 protein utilizes an IFN-dependent pathway to regulate viral early gene expression. PLoS Pathogens. 15(5). e1007743–e1007743. 13 indexed citations
6.
Sprinzl, Martin F., Martha M. Kirstein, Sandra Koch, et al.. (2018). Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular Carcinoma. Liver Cancer. 8(5). 387–402. 19 indexed citations
7.
Koch, Sandra, et al.. (2017). Kaposi sarcoma herpesvirus pathogenesis. Philosophical Transactions of the Royal Society B Biological Sciences. 372(1732). 20160275–20160275. 83 indexed citations
8.
Labenz, Christian, Sandra Koch, Yvonne Huber, et al.. (2017). Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib. Digestive Diseases. 36(1). 78–88. 7 indexed citations
9.
Koch, Sandra, Guigen Zhang, Magdalena Weidner-Glunde, et al.. (2017). Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency. PLoS Pathogens. 13(4). e1006335–e1006335. 37 indexed citations
10.
Kloeckner, Roman, Michael B. Pitton, Christoph Dueber, et al.. (2016). Validation of Clinical Scoring Systems ART and ABCR after Transarterial Chemoembolization of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology. 28(1). 94–102. 30 indexed citations
11.
Grimm, Daniela, Veronika Weyer, Anja Lautem, et al.. (2016). Organic Cation Transporter 1 (OCT1) mRNA expression in hepatocellular carcinoma as a biomarker for sorafenib treatment. BMC Cancer. 16(1). 94–94. 33 indexed citations
12.
Weinmann, Arndt, Thomas Sattler, Annette Grambihler, et al.. (2014). Predictive Scores in Primary Biliary Cirrhosis. Journal of Clinical Gastroenterology. 49(5). 438–447. 8 indexed citations
13.
Wörns, Marcus A., Sandra Koch, Jens U. Marquardt, et al.. (2012). The impact of patient and tumour baseline characteristics on the overall survival of patients with advanced hepatocellular carcinoma treated with sorafenib. Digestive and Liver Disease. 45(5). 408–413. 28 indexed citations
14.
Münzel, Martin, Toni Pfaffeneder, Felix Gnerlich, et al.. (2011). Improved Synthesis and Mutagenicity of Oligonucleotides Containing 5‐Hydroxymethylcytosine, 5‐Formylcytosine and 5‐Carboxylcytosine. Chemistry - A European Journal. 17(49). 13782–13788. 74 indexed citations
15.
Koch, Sandra, Jörg T. Epplen, Norbert Müller, et al.. (2005). Association of multiple sclerosis with ILT6 deficiency. Genes and Immunity. 6(5). 445–447. 41 indexed citations
16.
Koch, Sandra, et al.. (2003). Alginate encapsulation of genetically engineered mammalian cells: comparison of production devices, methods and microcapsule characteristics. Journal of Microencapsulation. 20(3). 303–316. 77 indexed citations
17.
Honecker, Friedemann, Frank Mayer, Hans Stoop, et al.. (2003). Xeroderma Pigmentosum Group A Protein and Chemotherapy Resistance in Human Germ Cell Tumors. Laboratory Investigation. 83(10). 1489–1495. 26 indexed citations
18.
Koch, Sandra, Frank Mayer, Friedemann Honecker, Marcus M. Schittenhelm, & Carsten Bokemeyer. (2003). Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro. British Journal of Cancer. 89(11). 2133–2139. 103 indexed citations
19.
Kollmannsberger, Christian, Frank Mayer, H. Preßler, et al.. (2002). Absence of c‐KIT and members of the epidermal growth factor receptor family in refractory germ cell cancer. Cancer. 95(2). 301–308. 35 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuyoshi Ohkawa Breakdown of academic impact, for papers by Masaaki Kondo Breakdown of academic impact, for papers by Sabino Russi Breakdown of academic impact, for papers by Abeer A. Bahnassy Breakdown of academic impact, for papers by Mee Soo Chang Breakdown of academic impact, for papers by Shilpa Chokshi Breakdown of academic impact, for papers by Hyun Young Woo Breakdown of academic impact, for papers by H. P. Dienes Breakdown of academic impact, for papers by Abdel‐Rahman N. Zekri Breakdown of academic impact, for papers by Liming Chen
Rankless by CCL
2026